Deal summary reprinted from Strategic Transactions - July 2009
Edwards Lifesciences has agreed to sell its hemofiltration product line (also called continuous renal replacement therapy (CRRT)) from its Critical Care unit to Baxter International, its long-term supplier. Find out more...
Find out more about what our Strategic Transactions - The Device Deal Database can do for you.
Strategic Transactions - The Device Deal Database provides expanded information, including:
- Comprehensive Deal Records
- Complete Financial Information
- Extensive Company Profiles
- Access to important SEC Documents
- Links to related articles
Contact: James DeFalco at: +1 (203) 838-4401 x104 or firstname.lastname@example.org.